David J. Behm

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

Robert N. Willette, Weike Bao, Sandhya S. Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 295 citations

Life Sciences, Pharmacology, Physiology +17

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

David G. Johns, David J. Behm, Deborah J. Walker et al. · British Journal of Pharmacology · 2007 · 243 citations · Full text

Medicine, Pharmacology, Cell Signaling +14

Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities

Chris P. Doe, Ross Bentley, David J. Behm et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 156 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors

Krista Goodman, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 156 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor

Patricia L. Podolin, Brian Bolognese, Joseph Foley et al. · Prostaglandins & Other Lipid Mediators · 2013 · 111 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14